Author: Hippocratic Post

‘Critical mass’ of scientists launches Institute to tackle infectious disease threats: Imperial College London has launched a pioneering new Institute to tackle some of the biggest challenges in infectious disease. The new Institute of Infection brings together one of the largest critical masses of researchers working across infectious disease, anywhere in the world. Building on the […]

Read More… from Institute launch to tackle infectious disease threats

A video educating about the importance of checking your Pulse with guidance on what to do. […]

Read More… from The importance of checking your Pulse

News Release: Merck and Ridgeback’s Investigational Oral Antiviral Molnupiravir Reduced the Risk of Hospitalization or Death by Approximately 50 Percent Compared to Placebo for Patients with Mild or Moderate COVID-19 in Positive Interim Analysis of Phase 3 Study At the Interim Analysis, 7.3 Percent of Patients Who Received Molnupiravir Were Hospitalized Through Day 29, Compared […]

Read More… from Merck and Ridgeback’s Antiviral Molnupiravir trial

The type of cancer treatment influences vaccine response: Cancer patients are at increased risk of SARS-CoV-2 infection and severe COVID-19 courses. Coronavirus vaccination is generally recommended for cancer patients, but so far little is known about how well they respond to the vaccine. In a study now published in the high-ranking journal JAMA Oncology (Impact […]

Read More… from Cancer Treatment influences vaccine response

Novel fluorescence imaging assay gives new insight to develop biomimetic nanoparticles for targeted cancer therapy. Cell membrane coated biomimetic nanoparticles (NPs) have been widely studied in nanomedicine because of their unique properties such as immune escaping, long blood circulation, specific molecular recognition and efficient cancer targeting, indicating a great potential in targeted cancer therapy. However, […]

Read More… from New imaging for targeted cancer therapy